Normann Steiner

689 total citations
55 papers, 471 citations indexed

About

Normann Steiner is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Normann Steiner has authored 55 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 20 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Normann Steiner's work include Multiple Myeloma Research and Treatments (20 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Normann Steiner is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Lymphoma Diagnosis and Treatment (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Normann Steiner collaborates with scholars based in Austria, Italy and Germany. Normann Steiner's co-authors include Eberhard Gunsilius, Georg Göbel, Wolfgang Willenbacher, Gerold Untergasser, Karin Jöhrer, Michael Mian, Patrizia Mondello, Roman Hájek, Johann Kern and Wolfgang Prokop and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Normann Steiner

52 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Normann Steiner Austria	14	219	191	180	108	98	55	471
Łukasz Bołkuń Poland	14	187 0.9×	160 0.8×	181 1.0×	78 0.7×	111 1.1×	52	510
Ning‐ning Shan China	15	135 0.6×	86 0.5×	309 1.7×	132 1.2×	100 1.0×	49	603
Michiaki Koike Japan	12	187 0.9×	129 0.7×	178 1.0×	150 1.4×	100 1.0×	48	509
Milada S. Vala United States	14	349 1.6×	261 1.4×	437 2.4×	96 0.9×	177 1.8×	20	860
Masaharu Nobuyoshi Japan	13	424 1.9×	307 1.6×	384 2.1×	58 0.5×	48 0.5×	22	720
Laxmi Narayana Buddharaju United States	5	272 1.2×	191 1.0×	269 1.5×	32 0.3×	92 0.9×	10	530
Plamen Kossev United States	9	185 0.8×	238 1.2×	122 0.7×	165 1.5×	101 1.0×	13	611
Michael Voralia Canada	11	229 1.0×	268 1.4×	263 1.5×	309 2.9×	263 2.7×	25	681
Julie A. Di Paolo United States	9	100 0.5×	134 0.7×	116 0.6×	76 0.7×	131 1.3×	17	521
Shou Ching Tang Canada	6	100 0.5×	200 1.0×	177 1.0×	43 0.4×	65 0.7×	7	506

Countries citing papers authored by Normann Steiner

Since Specialization

Citations

This map shows the geographic impact of Normann Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Normann Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Normann Steiner more than expected).

Fields of papers citing papers by Normann Steiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Normann Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Normann Steiner. The network helps show where Normann Steiner may publish in the future.

Co-authorship network of co-authors of Normann Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of Normann Steiner. A scholar is included among the top collaborators of Normann Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Normann Steiner. Normann Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steiner, Normann, Evgeny Klyuchnikov, Anita Badbaran, et al.. (2024). Impact of TP53 Mutation on Outcome after Allogeneic Stem Cell Transplantation for Patients with MDS/AML Not in Complete Remission. Blood. 144(Supplement 1). 3571–3571. 1 indexed citations

Massoud, Radwan, Evgeny Klyuchnikov, Normann Steiner, et al.. (2024). Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia Patients. Transplantation and Cellular Therapy. 31(1). 20.e1–20.e14. 1 indexed citations

Steiner, Normann, Radwan Massoud, Johanna Richter, et al.. (2024). Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post‐Transplant Cyclophosphamide in MRD‐Negative but Not in MRD‐Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission. European Journal Of Haematology. 114(1). 79–88.

Göbel, Georg, et al.. (2024). Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents. Cancers. 16(22). 3744–3744.

Knop, Stefan, Miriam Kull, Richard Greil, et al.. (2023). Carfilzomib, lenalidomide, and dexamethasone (KRd) versus elotuzumab and KRd in transplant-eligible patients with newly diagnosed multiple myeloma: Post-induction response and MRD results from an open-label randomized phase 3 study.. Journal of Clinical Oncology. 41(16_suppl). 8000–8000. 7 indexed citations

Jukic, Emina, Markus A. Keller, Irmgard Verdorfer, et al.. (2022). Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma. European Journal Of Haematology. 110(3). 296–304. 6 indexed citations

Brummer, Christina, Daniel Wolff, Udo Holtick, et al.. (2022). High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group. Transplantation and Cellular Therapy. 28(6). 337.e1–337.e10. 14 indexed citations

Steiner, Normann, Wolfgang Willenbacher, Brigitte Kircher, et al.. (2022). Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years. Anticancer Research. 42(12). 5825–5832. 2 indexed citations

Steiner, Normann, Laura Brunelli, Georg Göbel, et al.. (2021). Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience. Annals of Hematology. 100(3). 809–816. 2 indexed citations

10.

Steiner, Normann, Karin Jöhrer, Georg Göbel, et al.. (2020). The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis. Cancers. 12(9). 2341–2341. 4 indexed citations

11.

Steiner, Normann, Andreas Kronbichler, Hannes Neuwirt, et al.. (2020). Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury. Journal of Nephrology. 34(4). 1263–1270. 4 indexed citations

12.

Steiner, Normann, Udo Müller, Roman Hájek, et al.. (2018). The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets. PLoS ONE. 13(8). e0202045–e0202045. 41 indexed citations

13.

Steiner, Normann, Roman Hájek, Sabina Ševčı́ková, et al.. (2018). The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma. Anticancer Research. 38(9). 5087–5092. 6 indexed citations

14.

Steiner, Normann, Roman Hájek, Sabina Ševčı́ková, et al.. (2017). High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma. PLoS ONE. 12(7). e0181487–e0181487. 11 indexed citations

15.

Steiner, Normann, Roman Hájek, Karin Jöhrer, et al.. (2017). Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma. Oncotarget. 8(34). 56243–56254. 16 indexed citations

16.

Mondello, Patrizia, Normann Steiner, Wolfgang Willenbacher, et al.. (2016). Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study. Annals of Hematology. 95(7). 1107–1114. 22 indexed citations

17.

Steiner, Normann, David Nachbaur, Paul König, Wolfgang Willenbacher, & Eberhard Gunsilius. (2015). Long-term control in a patient with refractory multiple myeloma by oral cyclophosphamide and dexamethasone.. PubMed. 35(4). 2165–8. 4 indexed citations

18.

Mondello, Patrizia, Normann Steiner, Wolfgang Willenbacher, et al.. (2015). 90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?. Clinical Lymphoma Myeloma & Leukemia. 16(2). 82–88. 4 indexed citations

19.

Amann, Arno, Normann Steiner, & Eberhard Gunsilius. (2015). Bevacizumab: an option for refractory epistaxis in hereditary haemorrhagic telangiectasia. Wiener klinische Wochenschrift. 127(15-16). 631–634. 3 indexed citations

20.

Steiner, Normann, et al.. (1977). Incidence of hepatitis B surface antigen (HBsAg) in some areas of Romania.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(2). 141–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact